Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Antinuclear Antibody Testing Market to Garner Revenue of $2,766 million and CAGR of 13.0% in 2019-2027 - Exclusive Report [247 pages] by Research Dive

This image opens in the lightbox

News provided by

Research Dive

09 Dec, 2020, 12:00 GMT

Share this article

Share toX

Share this article

Share toX

The antinuclear antibody testing market will grow in the coming years. The reagents & assay kits sub-segment will be the most profitable. Rheumatoid arthritis sub-segment will be the most lucrative and North American Region will rule the market.

NEW YORK, Dec. 9, 2020 /PRNewswire/ -- Research Dive has published a new report titled, 'Antinuclear Antibody Testing Market, By Product (Reagents & Assay Kits, Systems And Software & Services), Technique (ELISA, Immunofluorescence Assay And Multiplex Assay), Application (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjogren's Syndrome, Scleroderma And Others), End Use (Hospitals, Clinical Laboratories, Physician Office Laboratories And Others), Regional Outlook (North America, Europe, Asia-Pacific, And LAMEA): Global Opportunity Analysis And Industry Forecast, 2019–2027.'

According to the report published by Research Dive, the Antinuclear Antibody Testing Market is anticipated to surpass $2,766.5 million by 2027, from a substantial market size of $1,080.1 million in 2019, with CAGR of 13.0% during the predicted forecast timeframe.  

Regional Analysis

North America region to rule the market and this region was accounted for $392.3 million in 2019 and is projected to escalate with significant CAGR of $11.9% in the analyzed timeframe. Rise in prevalence of autoimmune diseases in the North American region is predicted to boost the market growth. Moreover, with increase in population, autoimmune disease will automatically rise. These factors are responsible for the market growth in the forecast period.

Get Access to Sample Report of Antinuclear Antibody Testing Market @ https://www.researchdive.com/download-sample/8330

Key Segment Findings of the Market

The report divides the market into segments based on product, technique, application, end-use, and regional outlook.

  • Reagents and Assay kits sub-segment to be the most profitable as the sub-segment is predicted to increase from market size of $642.1 million in 2019 and achieve notable CAGR of 13.6% in the forecast period. Increase in the usage of these kits for varied research and development projects in order to understand different types of diseases is anticipated to enhance the sub-segment market during the forecast period.
  • ELISA sub-segment to gain maximum revenue and the sub-segment is expected to grow in the forecast period because it shows results faster than any other testing methods. The market share stood at $430.5 million in 2019 and is estimated to enhance with considerable CAGR of 13.7% during the forecast period.
  • Rheumatoid arthritis sub-segment to be the most lucrative and the sub-segment is projected to escalate with a CAGR of 13.5% during the forecast period and the market size was predicted to be $752.3 million in 2019. Increase in prevalence of rheumatoid arthritis disease and surge in geriatric population is anticipated to be the major factors fueling the market growth in forecast period.
  • Hospital sub-segment to garner huge profits and sub-segment was anticipated to hold market share of $452.3 million in the year 2019 and is estimated to enhance with a CAGR of 12.5% in the forecast timeframe. Major reasons for the market growth are outpatient services, patient satisfaction, and rise in home care facilities.

Research Dive Anniversary Offer

Avail Reports with Additional Benefits:

  • • Free Excel Data Pack
  • • 20% Free Customization
  • • Impact of COVID-19 On The Market

Grab the OFFER: https://www.researchdive.com/request-for-customization/8330

Offer Valid till 31st December 2020**

Factors Affecting the Market Growth

End-users are demanding antinuclear antibody tests at high rate due to the rise in cases pertaining to autoimmune diseases. This aspect is predicted to be responsible for the growth of the antinuclear antibody market in the estimated forecast period. Moreover, government's initiatives to build awareness about medical insurances have pushed numerous people under the safety cover of health policies.

Nevertheless, the growth of the market is hindered due to strict government rules on obtaining antinuclear antibody medical devices. The stringent rules are due to concerns related to the consistency of testing devices. Furthermore, requirement of heavy investments for installing and setting up of testing devices is estimated to restrain the market growth as well. On the other hand, investments in healthcare facilities and testing kits are projected to create tremendous opportunities in the global antinuclear antibody testing market.

COVID-19 Impact on Antinuclear Antibody Testing Market

The Covid-19 pandemic is predicted to impact the antinuclear antibody testing market in a positive way and grow rapidly during the pandemic phase. The primary reason for this rise in market is due to surge in number of people opting for antinuclear antibody tests. These tests confirm the presence of autoimmune disorders in a persons' body, and hence it is necessary to detect it.

Get Access to COVID-19 Impact Analysis Report https://www.researchdive.com/connect-to-analyst/8330

Key Market Players and Business Strategies

Some of the significant antinuclear antibody testing market players includes

1.  Bio-Rad Laboratories, Inc.

2.  Erba Diagnostics

3.  Trinity Biotech Plc.

4.  Antibodies Incorporated

5.  Thermo Fisher Scientific

6.  EUROIMMUN Medizinische Labordiagnostika AG

7.  Inova Diagnostics, Inc

8.  Immuno Concepts NA Ltd.

9.  ZEUS Scientific, Inc.

The key players are enhancing their efforts to improve product quality, launch new products, acquisitions, and product development. Apart from this, the report also summarizes various features of all the prominent players functioning in the market such as developments, financial performance, SWOT scrutiny, latest strategic moves, and product portfolio. - Inquire and Get Quick Access to Top Companies Development Strategies Summary Report [80 pages]

 More about Antibody Testing:

Antinuclear Antibody Testing: What is it, When to Take the Test, Interpretations of Test, and Autoimmune Diseases Associated with it

Covid-19 Pandemic Leads to Additional Surge of the Global Antinuclear Antibody Testing Market

Top Trending topics of Medical Devices & Supplies

  1.  Intelligent Intravenous Infusion Pumps Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 – Download Sample Report
  2.  Drug Designing Tools Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 – Download Sample Report
  3.  Biopreservation Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 – Download Sample Report
  4.  Veterinary Laser Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 – Download Sample Report

About Research Dive

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York NY 10005
(P) +91-(788)-802-9103 (India)
+1-(917)-444-1262 (US)
Toll Free: 1-888-961-4454
E-mail: support@researchdive.com
Website: https://www.researchdive.com
Blog:  https://www.researchdive.com/blog/
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521

Logo: https://mma.prnewswire.com/media/997523/Research_Dive_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.